Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jock Murray

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Clinical Medicine (London, England)|August 27, 2003
Samuel Johnson: his ills, his pills and his physician friendsT Jock Murray
ACP Journal Club|September 5, 2003
Mitoxantrone slowed progression of disability and reduced relapses in multiple sclerosisT Jock Murray
Expert Opinion on Drug Safety|March 1, 2006
The cardiac effects of mitoxantrone: do the benefits in multiple sclerosis outweigh the risks?T Jock Murray
Current Neurology and Neuroscience Reports|June 14, 2022
The History of Diagnosis and Treatment of MS: a Brief OverviewT Jock Murray
Mcgill Journal of Medicine : MJM : an International Forum for the Advancement of Medical Sciences by Students|September 16, 2009
Read any good books lately?T Jock Murray
Journal of the Neurological Sciences|February 10, 2009
The history of multiple sclerosis: the changing frame of the disease over the centuriesT Jock Murray
Current Medical Research and Opinion|March 5, 2008
Efficacy and tolerability of intramuscular interferon beta-1a compared with subcutaneous interferon beta-1a in relapsing MS: results from PROOFAlireza Minagara, T Jock Murray,
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 27, 2017
Dilemmas in medical ethics in the age of big dataSamuel K Ludwin, T Jock Murray
Neurology|April 26, 2015
Escalating MS drug costs in the US: Puzzling, troubling, and suspiciousT Jock Murray, Murray G Brown
Neurology|April 13, 2005
Treating fatigue in patients with MS: one step forward, one step backSteven R Schwid, T Jock Murray
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Clinical Medicine (London, England)|August 27, 2003
Samuel Johnson: his ills, his pills and his physician friendsT Jock Murray
ACP Journal Club|September 5, 2003
Mitoxantrone slowed progression of disability and reduced relapses in multiple sclerosisT Jock Murray
Expert Opinion on Drug Safety|March 1, 2006
The cardiac effects of mitoxantrone: do the benefits in multiple sclerosis outweigh the risks?T Jock Murray
Current Neurology and Neuroscience Reports|June 14, 2022
The History of Diagnosis and Treatment of MS: a Brief OverviewT Jock Murray
Mcgill Journal of Medicine : MJM : an International Forum for the Advancement of Medical Sciences by Students|September 16, 2009
Read any good books lately?T Jock Murray
Journal of the Neurological Sciences|February 10, 2009
The history of multiple sclerosis: the changing frame of the disease over the centuriesT Jock Murray
Current Medical Research and Opinion|March 5, 2008
Efficacy and tolerability of intramuscular interferon beta-1a compared with subcutaneous interferon beta-1a in relapsing MS: results from PROOFAlireza Minagara, T Jock Murray,
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 27, 2017
Dilemmas in medical ethics in the age of big dataSamuel K Ludwin, T Jock Murray
Neurology|April 26, 2015
Escalating MS drug costs in the US: Puzzling, troubling, and suspiciousT Jock Murray, Murray G Brown
Neurology|April 13, 2005
Treating fatigue in patients with MS: one step forward, one step backSteven R Schwid, T Jock Murray
Pageof 4